seventy patients candidate to gynecological surgery ( for benign conditions ) and 50 candidate to surgery for malignancies were randomly allocated either to defibrotide ( 400 mg b.i.d . im from the day before operation to the 7th postoperative day , n = 60 ) or to calcium heparin ( 5000 iu t.i.d . sc from the operation to the 7th postoperative day , n = 70 ) .
C0038902
gynecological surgery
C0543467
operation